Abstract |
Between October 2012 and October 2015, we conducted a community trial to assess the impact of semi-annual (twice yearly) community treatment with albendazole on lymphatic filariasis in Seke Pembe, a village in the Republic of the Congo. Semi-annual community treatment with albendazole has been continued in the community since October 2015. We conducted an additional parasitological assessment survey in October 2019, 6 months after the 14th round of semi-annual treatment. Between October 2012 and October 2015, Wuchereria bancrofti antigenemia and microfilaremia rates in the community had decreased from 17.3% to 4.7% and from 5.3% to 0.3%, respectively. In October 2019, the antigenemia rate had decreased further to 2.8% (19 of 687). No microfilariae were found in night blood smears from persons with circulating filarial antigenemia (0 of 16), suggesting that W. bancrofti transmission has been interrupted in Seke Pembe. Semi-annual albendazole treatments also reduced significantly infection rates with soil-transmitted helminths.
|
Authors | Sébastien D S Pion, Cédric B Chesnais, Gary J Weil, Frédéric Louya, Michel Boussinesq, François Missamou |
Journal | The American journal of tropical medicine and hygiene
(Am J Trop Med Hyg)
Vol. 106
Issue 2
Pg. 729-731
(12 20 2021)
ISSN: 1476-1645 [Electronic] United States |
PMID | 34929673
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Helminth
- Filaricides
- Soil
- Albendazole
|
Topics |
- Adolescent
- Adult
- Albendazole
(therapeutic use)
- Antigens, Helminth
(blood)
- Child
- Congo
(epidemiology)
- Elephantiasis, Filarial
(drug therapy, transmission)
- Female
- Filaricides
(therapeutic use)
- Helminthiasis
(classification, drug therapy, epidemiology, parasitology)
- Humans
- Male
- Mass Drug Administration
(standards, statistics & numerical data)
- Middle Aged
- Public Health
(methods, standards, statistics & numerical data)
- Soil
(parasitology)
- Young Adult
|